Case of a Сombination of Lupus Erythematosus, Antiphospholipid Syndrome and Myocardial Infarction

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology characterized by a wide range of clinical manifestations with damage to various organs and systems of the body. There are bad prognostic factors for SLE: damage to the heart, kidney, central nervous system, the d...

Full description

Saved in:

Bibliographic Details
Published in:	Kardiologiia Vol. 59; no. 12; p. 92
Main Authors:	Kosheleva, N A, Nikitina, N M, Andreeva, E U
Format:	Journal Article
Language:	English Russian
Published:	Russia (Federation) 17-12-2019
Subjects:	Antiphospholipid Syndrome Atherosclerosis Female Humans Lupus Erythematosus, Systemic Myocardial Infarction Risk Factors
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology characterized by a wide range of clinical manifestations with damage to various organs and systems of the body. There are bad prognostic factors for SLE: damage to the heart, kidney, central nervous system, the development of hematological crises and secondary antiphospholipid syndrome. A number of authors consider systemic lupus erythematosus a "new" risk factor for atherosclerosis. The overall risk of myocardial infarction (MI) in patients with SLE is 10 times higher than in the general population. The article presents clinical case report of the development of myocardial infarction in a woman with SLE, receiving therapy for secondary antiphospholipid syndrome.
ISSN:	0022-9040
DOI:	10.18087/cardio.2019.12.n610